A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colon
高选择性 PI3Kδ 抑制剂 BGB-10188 表现出优异的临床前抗肿瘤活性，并降低了结肠癌的靶向副作用
期刊:Neoplasia
影响因子:
doi:10.1016/j.neo.2024.101053
Xiao Yang, Huichen Bai, Xi Yuan, Xiaolong Yang, Ye Liu, Mingming Guo, Nan Hu, Beibei Jiang, Zeqin Lian, Zhilong Ma, Jingyuan Wang, Xuebing Sun, Taichang Zhang, Dan Su, Yue Wu, Jing Li, Fan Wang, Zhiwei Wang, Lai Wang, Xuesong Liu, Xiaomin Song
